-
1
-
-
0019458108
-
Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs
-
Toru M, Matsuda O, Makiguchi K, Sugano K: Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs. J Nerv Ment Dis 1981;169:324-327.
-
(1981)
J Nerv Ment Dis
, vol.169
, pp. 324-327
-
-
Toru, M.1
Matsuda, O.2
Makiguchi, K.3
Sugano, K.4
-
2
-
-
0018638316
-
Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents
-
Clark WG: Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents. Neurosci Biobehav Rev 1979;3:179-231.
-
(1979)
Neurosci Biobehav Rev
, vol.3
, pp. 179-231
-
-
Clark, W.G.1
-
3
-
-
0027200680
-
A novel CYP2D6 mutant gene associated with Parkinson's disease
-
Tsuneoka Y, Matsuo Y, Iwahashi K, Takeuchi H, Ichikawa Y: A novel CYP2D6 mutant gene associated with Parkinson's disease. J Biochem 1993;114:263-266.
-
(1993)
J Biochem
, vol.114
, pp. 263-266
-
-
Tsuneoka, Y.1
Matsuo, Y.2
Iwahashi, K.3
Takeuchi, H.4
Ichikawa, Y.5
-
4
-
-
0023754383
-
Xenobiotic and endobiotic inhibitions of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism
-
Fonne-Pfister R, Meyer UA: Xenobiotic and endobiotic inhibitions of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism. Biochem Pharmacol 1988;37:3829-3835.
-
(1988)
Biochem Pharmacol
, vol.37
, pp. 3829-3835
-
-
Fonne-Pfister, R.1
Meyer, U.A.2
-
5
-
-
0024993985
-
Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: The behavioral and biochemical changes
-
Yoshida M, Niwa T, Nagatsu T: Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: The behavioral and biochemical changes. Neurosci Lett 1992;119: 109-113.
-
(1992)
Neurosci Lett
, vol.119
, pp. 109-113
-
-
Yoshida, M.1
Niwa, T.2
Nagatsu, T.3
-
6
-
-
0025136874
-
Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible Parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer
-
Ohta S, Tachikawa O, Makino Y, Tasaki Y, Hirobe M: Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible Parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer. Life Sci 1990;46:599-605.
-
(1990)
Life Sci
, vol.46
, pp. 599-605
-
-
Ohta, S.1
Tachikawa, O.2
Makino, Y.3
Tasaki, Y.4
Hirobe, M.5
-
7
-
-
0022408175
-
Ecogenetics of Parkinson's disease: 4-Hydroxylation of debrisoquine
-
Barbeau A, Cloutier T, Roy M, Plasse L, Paris S, Poirier J: Ecogenetics of Parkinson's disease: 4-Hydroxylation of debrisoquine. Lancet 1985; ii:1213-1216.
-
(1985)
Lancet
, vol.2
, pp. 1213-1216
-
-
Barbeau, A.1
Cloutier, T.2
Roy, M.3
Plasse, L.4
Paris, S.5
Poirier, J.6
-
8
-
-
0026589459
-
Mutant debrisoquine hydroxylation genes in Parkinson's disease
-
Armstrong M, Daly AK, Chalerton S, Bateman DM, Idle JR: Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992; 339:1017-1018.
-
(1992)
Lancet
, vol.339
, pp. 1017-1018
-
-
Armstrong, M.1
Daly, A.K.2
Chalerton, S.3
Bateman, D.M.4
Idle, J.R.5
-
9
-
-
0027276869
-
Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans
-
Evans W, Relling M, Rahman A, McLeod H, Scott E, Lin J: Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans. J Clin Invest 1993;91:2150-2154.
-
(1993)
J Clin Invest
, vol.91
, pp. 2150-2154
-
-
Evans, W.1
Relling, M.2
Rahman, A.3
McLeod, H.4
Scott, E.5
Lin, J.6
-
10
-
-
0026747176
-
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease
-
Smith CAD, Gough AC, Leigh PN, Summers B, Harding AE, Maranganore DM, Sturman SG, Schapira AHV, Williams AC, Spurr NK, Wolf CR: Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-1377.
-
(1992)
Lancet
, vol.339
, pp. 1375-1377
-
-
Smith, C.A.D.1
Gough, A.C.2
Leigh, P.N.3
Summers, B.4
Harding, A.E.5
Maranganore, D.M.6
Sturman, S.G.7
Schapira, A.H.V.8
Williams, A.C.9
Spurr, N.K.10
Wolf, C.R.11
-
11
-
-
0028946508
-
A novel cytochrome P-45011D6 (CYPIID6) mutant gene associated with multiple system atrophy
-
Iwahashi K, Miyatake R, Tsuneoka Y, Matsuo Y, Ichikawa Y, Hosokawa K, Sato K, Hayabara T: A novel cytochrome P-45011D6 (CYPIID6) mutant gene associated with multiple system atrophy. J Neurol Neurosurg Psychiatry 1995; 58:263-264.
-
(1995)
J Neurol Neurosurg Psychiatry
, vol.58
, pp. 263-264
-
-
Iwahashi, K.1
Miyatake, R.2
Tsuneoka, Y.3
Matsuo, Y.4
Ichikawa, Y.5
Hosokawa, K.6
Sato, K.7
Hayabara, T.8
-
12
-
-
0022370639
-
Neuroleptic malignant syndrome
-
Levenson JL: Neuroleptic malignant syndrome. Am J Psychiatry 1985;142:1137-1145.
-
(1985)
Am J Psychiatry
, vol.142
, pp. 1137-1145
-
-
Levenson, J.L.1
-
13
-
-
0026662792
-
Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYRI) gene in individuals with malignant hyperthermia
-
Gillard EF, Otsu K, Fujii J, Duff C, De Leon S, Khanna VK, Bntt BA, Worton RG, MacLennan DH: Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYRI) gene in individuals with malignant hyperthermia. Genomics 1992; 13:1247-1254.
-
(1992)
Genomics
, vol.13
, pp. 1247-1254
-
-
Gillard, E.F.1
Otsu, K.2
Fujii, J.3
Duff, C.4
De Leon, S.5
Khanna, V.K.6
Bntt, B.A.7
Worton, R.G.8
MacLennan, D.H.9
-
14
-
-
0030597048
-
Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA
-
Miyatake R, Furukawa A, Matsushita M, Iwahashi K, Nakamura K, Ichikawa Y, Suwaki H: Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA. FEBS Lett 1996;395:123-126.
-
(1996)
FEBS Lett
, vol.395
, pp. 123-126
-
-
Miyatake, R.1
Furukawa, A.2
Matsushita, M.3
Iwahashi, K.4
Nakamura, K.5
Ichikawa, Y.6
Suwaki, H.7
-
15
-
-
0026519363
-
Debriso quine 4-monooxygenase and bufuralol 1-monooxygenase activities in bovine and rabbit tissues
-
Matsuo Y, Iwahashi K, Ichikawa Y: Debriso quine 4-monooxygenase and bufuralol 1-monooxygenase activities in bovine and rabbit tissues. Biochem Pharmacol 1992;43:1911-1919.
-
(1992)
Biochem Pharmacol
, vol.43
, pp. 1911-1919
-
-
Matsuo, Y.1
Iwahashi, K.2
Ichikawa, Y.3
-
16
-
-
0031410811
-
Relationship between the susceptibility for subacute myelo-opticoneuropathy (SMON) and polymorphisms of CYP2D6 and CYP2C19
-
Sakae Y, Iwahashi K, Nakamura K, Usuki T, Watanabe M, Hayahara T, Ameno K, Suwaki H: Relationship between the susceptibility for subacute myelo-opticoneuropathy (SMON) and polymorphisms of CYP2D6 and CYP2C19 (in Japanese). Jpn J Toxicol Environ Health 1997;43:376-382.
-
(1997)
Jpn J Toxicol Environ Health
, vol.43
, pp. 376-382
-
-
Sakae, Y.1
Iwahashi, K.2
Nakamura, K.3
Usuki, T.4
Watanabe, M.5
Hayahara, T.6
Ameno, K.7
Suwaki, H.8
-
17
-
-
0025996622
-
NMS and genetic drug oxidation
-
Otani K, Kaneko S, Fukushima Y, Chiba K, Ishizaki T: NMS and genetic drug oxidation. Br J Psychiatry 1991;159:595-596.
-
(1991)
Br J Psychiatry
, vol.159
, pp. 595-596
-
-
Otani, K.1
Kaneko, S.2
Fukushima, Y.3
Chiba, K.4
Ishizaki, T.5
|